Sandbox: sadaf: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 66: | Line 66: | ||
| align="center" style="background:#F5F5F5;" + | − | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + |[[Urine|Urinalysis]] | | align="center" style="background:#F5F5F5;" + |[[Urine|Urinalysis]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Increased risk in [[pregnancy]] | * Increased risk in [[pregnancy]] | ||
* Must be treated prior to an invasive urologic procedure | * Must be treated prior to an invasive urologic procedure | ||
Line 171: | Line 171: | ||
| align="center" style="background:#F5F5F5;" + | − | | align="center" style="background:#F5F5F5;" + | − | ||
| align="center" style="background:#F5F5F5;" + |Urine mycobacterial [[Polymerase chain reaction|PCR]] | | align="center" style="background:#F5F5F5;" + |Urine mycobacterial [[Polymerase chain reaction|PCR]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Past history of [[Tuberculosis|pulmonary TB]] | * Past history of [[Tuberculosis|pulmonary TB]] | ||
|- | |- | ||
Line 196: | Line 196: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |[[Urine culture]] | | align="center" style="background:#F5F5F5;" + |[[Urine culture]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Increased risk in patients with long−term foley [[Catheter|catheters]] | * Increased risk in patients with long−term foley [[Catheter|catheters]] | ||
* [[Candidiasis|Candida]] as the most prevalent fungus | * [[Candidiasis|Candida]] as the most prevalent fungus | ||
Line 211: | Line 211: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Tenderness (medicine)|Abdominal tenderness]] | * [[Tenderness (medicine)|Abdominal tenderness]] | ||
* [[Adnexa|Adnexal]] motion [[tenderness]] | * [[Adnexa|Adnexal]] motion [[tenderness]] | ||
Line 225: | Line 225: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |[[Polymerase chain reaction|PCR]] | | align="center" style="background:#F5F5F5;" + |[[Polymerase chain reaction|PCR]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Females might have concurrent chlamydial [[cervicitis]] | * Females might have concurrent chlamydial [[cervicitis]] | ||
* Must be considered in young, sexually active males | * Must be considered in young, sexually active males | ||
Line 239: | Line 239: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Tenderness (medicine)|Abdominal tenderness]] | * [[Tenderness (medicine)|Abdominal tenderness]] | ||
* [[Adnexa|Adnexal]] motion [[tenderness]] | * [[Adnexa|Adnexal]] motion [[tenderness]] | ||
Line 249: | Line 249: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
High false negative result | High false negative result | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Intracellular gram−negative [[Diplococcus|diplococci]] on [[Gram staining|gram stain]] | * Intracellular gram−negative [[Diplococcus|diplococci]] on [[Gram staining|gram stain]] | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 255: | Line 255: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |[[Nucleic acid amplification technique|Nucleic acid amplification]] testing (NAAT) | | align="center" style="background:#F5F5F5;" + |[[Nucleic acid amplification technique|Nucleic acid amplification]] testing (NAAT) | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Females might have concurrent cervical [[Gonorrhea|gonococcal infection]] | * Females might have concurrent cervical [[Gonorrhea|gonococcal infection]] | ||
* Must be considered in young, sexually active males | * Must be considered in young, sexually active males | ||
Line 276: | Line 276: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + | − | | align="center" style="background:#F5F5F5;" + | − | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Gram stain − | * Gram stain − | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 282: | Line 282: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |[[Polymerase chain reaction|PCR]] | | align="center" style="background:#F5F5F5;" + |[[Polymerase chain reaction|PCR]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Associated with complications of pregnancy | * Associated with complications of pregnancy | ||
|- | |- | ||
Line 295: | Line 295: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Painful [[Genital ulcer|genital ulcers]] | * Painful [[Genital ulcer|genital ulcers]] | ||
* Tender local inguinal [[lymphadenopathy]] | * Tender local inguinal [[lymphadenopathy]] | ||
Line 311: | Line 311: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |Clinical manifestation + [[Polymerase chain reaction|PCR]] | | align="center" style="background:#F5F5F5;" + |Clinical manifestation + [[Polymerase chain reaction|PCR]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Associated with extragenital complications, like [[Meningitis|aseptic meningitis]] | * Associated with extragenital complications, like [[Meningitis|aseptic meningitis]] | ||
* High risk of recurrence | * High risk of recurrence | ||
Line 325: | Line 325: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Rash]] | * [[Rash]] | ||
* Acute [[neuritis]] | * Acute [[neuritis]] | ||
Line 334: | Line 334: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Microscopic hematuria]] | * [[Microscopic hematuria]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 340: | Line 340: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Associated with lumbosacral [[dermatome]] involvement | * Associated with lumbosacral [[dermatome]] involvement | ||
|- | |- | ||
Line 501: | Line 501: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Leukocytosis]] ± | * [[Leukocytosis]] ± | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
Line 508: | Line 508: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Leukocyte esterase]] ± | * [[Leukocyte esterase]] ± | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 514: | Line 514: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |Clinical manifestation + [[Urine|urinalysis]] | | align="center" style="background:#F5F5F5;" + |Clinical manifestation + [[Urine|urinalysis]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Predicting [[Urinary tract infection|UTI]] in children who required clean intermittent [[Catheter|catheterization]] by routine [[Urine|urinalysis]] | * Predicting [[Urinary tract infection|UTI]] in children who required clean intermittent [[Catheter|catheterization]] by routine [[Urine|urinalysis]] | ||
|- | |- | ||
Line 999: | Line 999: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" |Henoch−Schönlein purpura | ! colspan="2" align="center" style="background:#DCDCDC;" + |Henoch−Schönlein purpura | ||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + |+ | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + |+ | |||
| align="center" style="background:#F5F5F5;" + |+ | |||
| align="center" style="background:#F5F5F5;" + |+ | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Proteinuria | * Proteinuria | ||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |[[Graft versus host disease|Graft versus host disease (GVHD)]] | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Graft versus host disease|Graft versus host disease (GVHD)]] |
Revision as of 20:09, 4 June 2018
Pyuria Differential Diagnosis
Differentiating the diseases that can cause pyuria:[1][2][3][4]
Category | Disease | Clinical manifestations | Para−clinical findings | Gold standard for diagnosis | Associated findings | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||||||||||||
Lab Findings | Imaging | ||||||||||||||||||||||||
Pain | Fever | N/V | Urinary symptoms | BP | Edema | Other | CBC | Electrolytes | Urinalysis | Ultrasound | CT scan | Other | |||||||||||||
Dysuria | Frequency | Urgency | Gross hematuria | Cell | Cast | Bacteriuria | Culture | Other | |||||||||||||||||
Infectious diseases | UTI[5] | Bacterial | Asymptomatic bacteriuria[6][7] | − | − | − | − | − | − | − | Nl | − | − | Nl | Nl | ± | − | + | − | − | − | − | − | Urinalysis |
|
Cystitis[8] | − | − | − | + | + | + | − | Nl | − | − | Nl | Nl | + | − | + | + | − | − | − | Urinalysis | |||||
Pyelonephritis[9] | + | + | + | + | + | + | − | Nl | − | − | WBC ↑ | Nl | + | WBC cast | + | + | − | − | − | Clinical manifestation + urinalysis | |||||
Viral[10][11] | − | − | + | + | + | + | ± | Nl | − | − | Nl | Nl | + | − | − | − | − | − | − | − | PCR viral load |
| |||
Tuberculosis[12][13][14][15] | − | ± | − | + | + | + | + | Nl | − | − | Nl | Nl | ± | − | − | Positive mycobacterial urine culture |
|
− | Pulmonary TB on chest CT | − | Urine mycobacterial PCR |
| |||
Fungal[16][17] | − | − | − | + | + | − | − | Nl | − | − | Nl | Nl | ± | − | − | + after several weeks of follow up | − | Hydronephrosis | − | − | Urine culture | ||||
STD | Chlamydia[18][19] | Chronic pelvic pain | − | − | + | + | − | − | Nl | − | Nl | Nl | + | − | − | + | − | − | − | − | PCR |
| |||
Gonococcus[20][21][22] | Chronic pelvic pain | − | − | + | + | − | − | Nl | − | Nl | Nl | + | − | − | +
High false negative result |
|
− | − | − | Nucleic acid amplification testing (NAAT) |
| ||||
Ureaplasma urealyticum[23] | − | − | − | + | + | − | − | Nl | − | − | Nl | Nl | + | − | − | − |
|
− | − | − | PCR |
| |||
Herpes simplex virus[24] | + | + | − | + | + | − | − | Nl | − |
|
Nl | Nl | + | − | − | Viral culture + | − | − | − | − | Clinical manifestation + PCR |
| |||
Herpes zoster[25] | − | − | − | + | + | − | − | Nl | − | Nl | Nl | + | − | − |
| ||||||||||
HPV | |||||||||||||||||||||||||
HIV | |||||||||||||||||||||||||
Prostatitis | |||||||||||||||||||||||||
Balanitis | |||||||||||||||||||||||||
Appendicitis | |||||||||||||||||||||||||
Category | Disease | Pain | Fever | N/V | Dysuria | Frequency | Urgency | Gross hematuria | BP | Edema | Other PE | CBC | Electrolytes | Cell | Cast | Bacteriuria | Culture | Other UA findings | Ultrasound | CT scan | Other imaging | Gold standard for diagnosis | Associated findings | ||
Non−infectious diseases | Urinary tract disorders | Urinary catheterization[26] | − | − | − | + | + | − | − | Nl | − | − | Nl | ↑ | − | + | + | − | − | − | Clinical manifestation + urinalysis |
| |||
Urinary tract stone | |||||||||||||||||||||||||
Urinary tract neoplasm | |||||||||||||||||||||||||
Urinary fistula | |||||||||||||||||||||||||
Interstitial cystitis | |||||||||||||||||||||||||
Vesicoureteral reflux | |||||||||||||||||||||||||
Hydronephrosis | |||||||||||||||||||||||||
Renal diseases | Polycystic kidney disease | ||||||||||||||||||||||||
Renal vein thrombosis | |||||||||||||||||||||||||
Interstitial nephritis | |||||||||||||||||||||||||
Papillary necrosis | |||||||||||||||||||||||||
IgA nephropathy | |||||||||||||||||||||||||
Renal transplant rejection | |||||||||||||||||||||||||
Disease | Pain | Fever | N/V | Dysuria | Frequency | Urgency | Gross hematuria | BP | Edema | Other PE | CBC | Electrolytes | Cell | Cast | Bacteriuria | Culture | Other UA findings | Ultrasound | CT scan | Other imaging | Gold standard for diagnosis | Associated findings | |||
Systemic disease | Malignant hypertension | ||||||||||||||||||||||||
Diabetic nephropathy | |||||||||||||||||||||||||
Sickle cell disease | |||||||||||||||||||||||||
Sarcoidosis | |||||||||||||||||||||||||
Systemic lupus erythematosus | |||||||||||||||||||||||||
Sjögren’s syndrome | |||||||||||||||||||||||||
Kawasaki's disease[27] | − | + | − | + | + | + | − | Nl | − | + | − | − | − | − | − | − | − | Clinical manifestation | |||||||
Henoch−Schönlein purpura | + | + | + | + |
|
||||||||||||||||||||
Graft versus host disease (GVHD) | |||||||||||||||||||||||||
Medication/toxin | Analgesic nephropathy | ||||||||||||||||||||||||
Contrast−induced nephropathy | |||||||||||||||||||||||||
Glucocorticoids | |||||||||||||||||||||||||
Toluene | |||||||||||||||||||||||||
Lead poisoning | |||||||||||||||||||||||||
Category | Disease | Pain | Fever | N/V | Dysuria | Frequency | Urgency | Gross hematuria | BP | Edema | Other PE | CBC | Electrolytes | Cell | Cast | Bacteriuria | Culture | Other UA findings | Ultrasound | CT scan | Other imaging | Gold standard for diagnosis | Associated findings |
- ↑ Wise, Gilbert J.; Longo, Dan L.; Schlegel, Peter N. (2015). "Sterile Pyuria". New England Journal of Medicine. 372 (11): 1048–1054. doi:10.1056/NEJMra1410052. ISSN 0028-4793.
- ↑ Stamm, Walter E. (1983). "Measurement of pyuria and its relation to bacteriuria". The American Journal of Medicine. 75 (1): 53–58. doi:10.1016/0002-9343(83)90073-6. ISSN 0002-9343.
- ↑ Groah, Suzanne; Perez-Losada, Marcos; Caldovic, Ljubica; Ljungberg, Inger; Sprague, Bruce; Castro-Nallar, Eduardo; Shah, Neel; Hsieh, Michael; Pohl, Hans (2015). "MP20-08 PYURIA AND ASYMPTOMATIC BACTERIURIA IS ASSOCIATED WITH NOVEL AND SPECIFIC URINE MICROBIOMES". The Journal of Urology. 193 (4): e226. doi:10.1016/j.juro.2015.02.980. ISSN 0022-5347.
- ↑ Shaikh, N.; Shope, T. R.; Hoberman, A.; Vigliotti, A.; Kurs-Lasky, M.; Martin, J. M. (2016). "Association Between Uropathogen and Pyuria". PEDIATRICS. 138 (1): e20160087–e20160087. doi:10.1542/peds.2016-0087. ISSN 0031-4005.
- ↑ Neal DE (February 2008). "Complicated urinary tract infections". Urol. Clin. North Am. 35 (1): 13–22, v. doi:10.1016/j.ucl.2007.09.010. PMID 18061020.
- ↑ Nicolle, Lindsay E. (2014). "Asymptomatic bacteriuria". Current Opinion in Infectious Diseases. 27 (1): 90–96. doi:10.1097/QCO.0000000000000019. ISSN 0951-7375.
- ↑ Nicolle, Lindsay E. (2015). "Asymptomatic Bacteriuria and Bacterial Interference". Microbiology Spectrum. 3 (5). doi:10.1128/microbiolspec.UTI-0001-2012. ISSN 2165-0497.
- ↑ Sabih A, Leslie SW. PMID 28613784. Missing or empty
|title=
(help) - ↑ Pietrucha-Dilanchian P, Hooton TM (December 2016). "Diagnosis, Treatment, and Prevention of Urinary Tract Infection". Microbiol Spectr. 4 (6). doi:10.1128/microbiolspec.UTI-0021-2015. PMID 28087935.
- ↑ Aboumohamed A, Flechner SM, Chiesa-Vottero A, Srinivas TR, Mossad SB (November 2014). "Disseminated adenoviral infection masquerading as lower urinary tract voiding dysfunction in a kidney transplant recipient". Clin. Nephrol. 82 (5): 332–6. doi:10.5414/CN107977. PMID 23816478.
- ↑ Santiago-Rodriguez TM, Ly M, Bonilla N, Pride DT (2015). "The human urine virome in association with urinary tract infections". Front Microbiol. 6: 14. doi:10.3389/fmicb.2015.00014. PMC 4304238. PMID 25667584.
- ↑ Altiparmak MR, Trabulus S, Balkan II, Yalin SF, Denizli N, Aslan G, Doruk HE, Engin A, Tekin R, Birengel S, Cetin BD, Arslan F, Turhan V, Mert A (August 2015). "Urinary tuberculosis: a cohort of 79 adult cases". Ren Fail. 37 (7): 1157–63. doi:10.3109/0886022X.2015.1057460. PMID 26123266.
- ↑ Verma AK, Mishra AK, Kumar M, Kant S, Singh A, Singh A (July 2016). "Renal tuberculosis presenting as acute pyelonephritis - A rarity". Indian J Tuberc. 63 (3): 210–213. doi:10.1016/j.ijtb.2015.07.010. PMID 27865246.
- ↑ Daher Ede F, da Silva GB, Barros EJ (January 2013). "Renal tuberculosis in the modern era". Am. J. Trop. Med. Hyg. 88 (1): 54–64. doi:10.4269/ajtmh.2013.12-0413. PMC 3541747. PMID 23303798.
- ↑ Czapka M, Shukla S, Slosar-Cheah M (August 2017). "Urine trouble: genitourinary tuberculosis and subsequent DRESS syndrome". BMJ Case Rep. 2017. doi:10.1136/bcr-2017-220440. PMID 28784884.
- ↑ Kim J, Kim DS, Lee YS, Choi NG (September 2011). "Fungal urinary tract infection in burn patients with long-term foley catheterization". Korean J Urol. 52 (9): 626–31. doi:10.4111/kju.2011.52.9.626. PMC 3198237. PMID 22025959.
- ↑ Carvalho M, Guimarães CM, Mayer JR, Bordignon GP, Queiroz-Telles F (December 2001). "Hospital-associated funguria: analysis of risk factors, clinical presentation and outcome". Braz J Infect Dis. 5 (6): 313–8. PMID 11980593.
- ↑ Matthews, R.S.; Bonigal, S.D.; Wise, R. (1990). "Sterile pyuria and Chlamydia trachomatis". The Lancet. 336 (8711): 385. doi:10.1016/0140-6736(90)91936-5. ISSN 0140-6736.
- ↑ Tayal SC, Pattman RS (1996). "Sterile pyuria: consider chlamydial infection". Br J Clin Pract. 50 (3): 166–7. PMID 8733337.
- ↑ Clarke M, Maskell R (December 1981). "Gonorrhoea presenting as "sterile" pyuria". Br Med J (Clin Res Ed). 283 (6305): 1546. PMC 1507898. PMID 6799059.
- ↑ Jephcott AE (August 1997). "Microbiological diagnosis of gonorrhoea". Genitourin Med. 73 (4): 245–52. PMC 1195851. PMID 9389943.
- ↑ Tomas ME, Getman D, Donskey CJ, Hecker MT (August 2015). "Overdiagnosis of Urinary Tract Infection and Underdiagnosis of Sexually Transmitted Infection in Adult Women Presenting to an Emergency Department". J. Clin. Microbiol. 53 (8): 2686–92. doi:10.1128/JCM.00670-15. PMC 4508438. PMID 26063863.
- ↑ Nassar FA, Abu-Elamreen FH, Shubair ME, Sharif FA (2008). "Detection of Chlamydia trachomatis and Mycoplasma hominis, genitalium and Ureaplasma urealyticum by polymerase chain reaction in patients with sterile pyuria". Adv Med Sci. 53 (1): 80–6. doi:10.2478/v10039-008-0020-1. PMID 18614434.
- ↑ Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE (August 2006). "Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States". JAMA. 296 (8): 964–73. doi:10.1001/jama.296.8.964. PMID 16926356.
- ↑ Chen, Po-Hong; Hsueh, Hsiu-Fang; Hong, Chang-Zern (2002). "Herpes zoster–associated voiding dysfunction: A retrospective study and literature review". Archives of Physical Medicine and Rehabilitation. 83 (11): 1624–1628. doi:10.1053/apmr.2002.34602. ISSN 0003-9993.
- ↑ Forster, C.S.; Haslam, D.B.; Jackson, E.; Goldstein, S.L. (2017). "Utility of a routine urinalysis in children who require clean intermittent catheterization". Journal of Pediatric Urology. 13 (5): 488.e1–488.e5. doi:10.1016/j.jpurol.2017.01.016. ISSN 1477-5131.
- ↑ Wirojanan J, Sopontammarak S, Vachvanichsanong P (March 2004). "Sterile pyuria in Kawasaki disease". Pediatr. Nephrol. 19 (3): 363. doi:10.1007/s00467-003-1394-8. PMID 14745638.